Literature DB >> 33280487

A Novel Three-Dimensional Skin Disease Model to Assess Macrophage Function in Diabetes.

Avi Smith1, Trishawna Watkins1, Georgios Theocharidis2, Irene Lang1, Maya Leschinsky1, Anna Maione1, Olga Kashpur1, Theresa Raimondo3, Sahar Rahmani3, Jeremy Baskin1, David Mooney3,4, Aristidis Veves2, Jonathan Garlick1.   

Abstract

A major challenge in the management of patients suffering from diabetes is the risk of developing nonhealing foot ulcers. Most in vitro methods to screen drugs for wound healing therapies rely on conventional 2D cell cultures that do not closely mimic the complexity of the diabetic wound environment. In addition, while three-dimensional (3D) skin tissue models of human skin exist, they have not previously been adapted to incorporate patient-derived macrophages to model inflammation from these wounds. In this study, we present a 3D human skin equivalent (HSE) model incorporating blood-derived monocytes and primary fibroblasts isolated from patients with diabetic foot ulcers (DFUs). We demonstrate that the monocytes differentiate into macrophages when incorporated into HSEs and secrete a cytokine profile indicative of the proinflammatory M1 phenotype seen in DFUs. We also show how the interaction between fibroblasts and macrophages in the HSE can guide macrophage polarization. Our findings take us a step closer to creating a human, 3D skin-like tissue model that can be applied to evaluate the response of candidate compounds needed for potential new foot ulcer therapies in a more complex tissue environment that contributes to diabetic wounds. Impact statement This study is the first to incorporate disease-specific, diabetic macrophages into a three-dimensional (3D) model of human skin. We show how to fabricate skin that incorporates macrophages with disease-specific fibroblasts to guide macrophage polarization. We also show that monocytes from diabetic patients can differentiate into macrophages directly in this skin disease model, and that they secrete a cytokine profile mimicking the proinflammatory M1 phenotype seen in diabetic foot ulcers. The data presented here indicate that this 3D skin disease model can be used to study macrophage-related inflammation in diabetes and as a drug testing tool to evaluate new treatments for the disease.

Entities:  

Keywords:  diabetes; diabetic foot ulcer; human skin equivalent; macrophage; skin model

Mesh:

Year:  2021        PMID: 33280487      PMCID: PMC8349718          DOI: 10.1089/ten.TEC.2020.0263

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  28 in total

Review 1.  Physiology and healing dynamics of chronic cutaneous wounds.

Authors:  W K Stadelmann; A G Digenis; G R Tobin
Journal:  Am J Surg       Date:  1998-08       Impact factor: 2.565

Review 2.  Wound healing and its impairment in the diabetic foot.

Authors:  Vincent Falanga
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

Review 3.  The role of endothelial function on the foot. Microcirculation and wound healing in patients with diabetes.

Authors:  H T Pham; P A Economides; A Veves
Journal:  Clin Podiatr Med Surg       Date:  1998-01       Impact factor: 1.231

Review 4.  Macrophage-based therapeutic strategies in regenerative medicine.

Authors:  Kara L Spiller; Timothy J Koh
Journal:  Adv Drug Deliv Rev       Date:  2017-05-16       Impact factor: 15.470

Review 5.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 6.  Macrophage plasticity and polarization in tissue repair and remodelling.

Authors:  Alberto Mantovani; Subhra K Biswas; Maria Rosaria Galdiero; Antonio Sica; Massimo Locati
Journal:  J Pathol       Date:  2012-11-29       Impact factor: 7.996

7.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; G E Reiber; E H Wagner
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

8.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair.

Authors:  C Wetzler; H Kämpfer; B Stallmeyer; J Pfeilschifter; S Frank
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

9.  Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing.

Authors:  Leena Pradhan Nabzdyk; Sarada Kuchibhotla; Patrick Guthrie; Maggie Chun; Michael E Auster; Christoph Nabzdyk; Steven Deso; Nicholas Andersen; Charalambos Gnardellis; Frank W LoGerfo; Aristidis Veves
Journal:  J Vasc Surg       Date:  2013-06-04       Impact factor: 4.268

Review 10.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

View more
  3 in total

Review 1.  Future Directions in Research in Transcriptomics in the Healing of Diabetic Foot Ulcers.

Authors:  Brandon J Sumpio; Zhuqing Li; Enya Wang; Ikram Mezghani; Georgios Theocharidis; Aristidis Veves
Journal:  Adv Ther       Date:  2022-10-20       Impact factor: 4.070

2.  Major Risk Factors Analysis of Pruritus Complicated by Type 2 Diabetes Mellitus and the Effect of Comprehensive Nursing Intervention.

Authors:  Qiu Ping Yang; Yuan Yuan Chen; Zhenzhen Li; Mingming Xu
Journal:  Front Surg       Date:  2022-02-15

3.  Novel 3D-Printed Cell Culture Inserts for Air-Liquid Interface Cell Culture.

Authors:  Magdalena Bauer; Magdalena Metzger; Marvin Corea; Barbara Schädl; Johannes Grillari; Peter Dungel
Journal:  Life (Basel)       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.